This program project continues its investigation of the cell and molecular biology of the four neuroendocrine cell types comprising the pancreatic islets, so as to clarify their inter-relationships and distinguishing features. Of particular relevance to the mechanism of type I diabetes are the unique qualities of the insulin producing beta cells, which are selectively destroyed, leaving the alpha, delta, and PP cells intact. An exciting candidate is the 65kd isoform of glutamic acid decarboxylase, which was discovered by Baekkeskov et al. in the context of this program project to be the '64kd' beta cell autoantigen in type I diabetes. GAD65 has been and will continue to be a major focus of this interactive program, with all three projects planning studies on the biology of GAD65. Our plans are: Project 1 (Hanahan) will produce mice carrying gene knockouts of GAD65 and betacellulin, a TGF-alpha family member expressed in beta cells, to assess the roles of these genes in embryogenesis and in islet development and function. The oncogene SV40 Tag will be integrated into the genes for somatostatin and pancreatic polypeptide, and gene-targeted mice produced, from which delta and PP cell tumors and tumor cell lines will be derived, to complete the set of representative islet cell lines. A cell type (mPAC) associated with juvenile islets will be investigated both for its potential as an islet progenitor, and as a target for pancreatic ductal adenocarcinoma. Project 2 (Baekkeskov) will characterize the biosynthetic pathway of GAD65, which is membrane anchored, and identify the sequences that elicit its subcellular localization to synaptic like micro-vesicles. Tansgenic mice over-expressing human GAD65 will be investigated to learn more about the normal functions of GAD in beta cells, and its ability to disrupt beta cell function through improper expression. Similarly, the GAD65 knockout mice will be studied to ascertain the physiological consequences of a failure to produce this enzyme. The capability of GAD to act as an autoantigen in beta cells of transgenic mice will be investigated, which should contribute to our understanding of its roles in the human autoimmune disease. Project 3 (German/Rutter) will investigate transcriptional regulation of genes implicated in islet cell function and disease, including the islet hormones, glucokinase, islet amyloid, and GAD65, using cell lines representative of differentiated and 'progenitor' islet cell types. The goal is to define the key transcriptional regulatory proteins that elicit cell type specificity among the closely inter-related alpha, beta, delta, and PP cells, with the expectation that this information will help explain the unique susceptibility of b cells to immune destruction. Having identified candidates for key islet regulatory factors, gene knockout mice will be produced to assess the importance of these factors for embryogenesis in general, and islet cell development and function in particular.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK041822-10
Application #
2749458
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Laughlin, Maren R
Project Start
1989-08-01
Project End
2001-07-31
Budget Start
1998-08-10
Budget End
2001-07-31
Support Year
10
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Wilson, Maria E; Scheel, David; German, Michael S (2003) Gene expression cascades in pancreatic development. Mech Dev 120:65-80
Sander, M; Sussel, L; Conners, J et al. (2000) Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127:5533-40
Shi, Y; Kanaani, J; Menard-Rose, V et al. (2000) Increased expression of GAD65 and GABA in pancreatic beta-cells impairs first-phase insulin secretion. Am J Physiol Endocrinol Metab 279:E684-94
Sander, M; Paydar, S; Ericson, J et al. (2000) Ventral neural patterning by Nkx homeobox genes: Nkx6.1 controls somatic motor neuron and ventral interneuron fates. Genes Dev 14:2134-9
Roll, U; Turck, C W; Gitelman, S E et al. (2000) Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in Type I diabetic patients. Diabetologia 43:598-608
Kanaani, J; Lissin, D; Kash, S F et al. (1999) The hydrophilic isoform of glutamate decarboxylase, GAD67, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane-anchored isoform, GAD65. J Biol Chem 274:37200-9
Schwartz, H L; Chandonia, J M; Kash, S F et al. (1999) High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 287:983-99
Smith, S B; Ee, H C; Conners, J R et al. (1999) Paired-homeodomain transcription factor PAX4 acts as a transcriptional repressor in early pancreatic development. Mol Cell Biol 19:8272-80
Bridgett, M; Cetkovic-Cvrlje, M; O'Rourke, R et al. (1998) Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes 47:1848-56
Damert, A; Machein, M; Breier, G et al. (1997) Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 57:3860-4

Showing the most recent 10 out of 27 publications